Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (2,4,5-trichlorophenoxy)acetic acid | increases expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:18579281 | 1,1-dichloroethene | decreases expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of C1QTNF4 mRNA | CTD | PMID:26682919 | 1,2-dimethylhydrazine | decreases expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of C1QTNF4 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of C1QTNF4 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | multiple interactions | ISO | C1qtnf4 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of C1QTNF4 mRNA | CTD | PMID:17942748 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | C1qtnf4 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | C1qtnf4 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | C1qtnf4 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of C1QTNF4 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of C1QTNF4 mRNA | CTD | PMID:32109520 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | decreases expression | ISO | C1QTNF4 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:26705709 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of C1QTNF4 mRNA | CTD | PMID:20188158 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | C1qtnf4 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of C1QTNF4 exon | CTD | PMID:33297965 | 4-hydroxyphenyl retinamide | increases expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | Fenretinide results in increased expression of C1QTNF4 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of C1QTNF4 mRNA | CTD | PMID:30047161 | acrylamide | decreases expression | ISO | C1QTNF4 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of C1QTNF4 mRNA | CTD | PMID:32763439 | Aflatoxin B2 alpha | decreases methylation | ISO | C1QTNF4 (Homo sapiens) | 6480464 | aflatoxin B2 results in decreased methylation of C1QTNF4 promoter | CTD | PMID:30157460 | all-trans-retinoic acid | increases expression | ISO | C1QTNF4 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of C1QTNF4 mRNA | CTD | PMID:23724009 | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of C1QTNF4 mRNA | CTD | PMID:30047161 | antirheumatic drug | increases expression | ISO | C1QTNF4 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of C1QTNF4 mRNA | CTD | PMID:24449571 | arsenous acid | decreases expression | ISO | C1QTNF4 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of C1QTNF4 mRNA | CTD | PMID:26705709 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of C1QTNF4 mRNA | CTD | PMID:21839799 | benzo[a]pyrene | decreases methylation | ISO | C1QTNF4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of C1QTNF4 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | C1QTNF4 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of C1QTNF4 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of C1QTNF4 mRNA | CTD | PMID:22228805 and PMID:27195522 | benzo[e]pyrene | increases methylation | ISO | C1QTNF4 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of C1QTNF4 promoter | CTD | PMID:30157460 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of C1QTNF4 mRNA | CTD | PMID:25181051 and PMID:30816183 | bisphenol A | increases expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | bisphenol A results in increased expression of C1QTNF4 mRNA | CTD | PMID:32156529 | bisphenol A | decreases expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of C1QTNF4 mRNA | CTD | PMID:35598803 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of C1QTNF4 promoter | CTD | PMID:22457795 | chlorpyrifos | increases expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of C1QTNF4 mRNA | CTD | PMID:37019170 | choline | multiple interactions | ISO | C1qtnf4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of C1QTNF4 mRNA | CTD | PMID:20938992 | cocaine | decreases expression | EXP | | 6480464 | Cocaine results in decreased expression of C1QTNF4 mRNA | CTD | PMID:17898221 | copper atom | increases expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | Copper results in increased expression of C1QTNF4 mRNA | CTD | PMID:18579281 | copper(0) | increases expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | Copper results in increased expression of C1QTNF4 mRNA | CTD | PMID:18579281 | copper(II) chloride | increases expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | cupric chloride results in increased expression of C1QTNF4 mRNA | CTD | PMID:17211630 | diarsenic trioxide | decreases expression | ISO | C1QTNF4 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of C1QTNF4 mRNA | CTD | PMID:26705709 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of C1QTNF4 mRNA | CTD | PMID:21266533 | dichloroacetic acid | increases expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of C1QTNF4 mRNA | CTD | PMID:28962523 | dorsomorphin | multiple interactions | ISO | C1QTNF4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of C1QTNF4 mRNA | CTD | PMID:30307764 | folic acid | multiple interactions | ISO | C1qtnf4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of C1QTNF4 mRNA | CTD | PMID:20938992 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of C1QTNF4 mRNA | CTD | PMID:22061828 | L-methionine | multiple interactions | ISO | C1qtnf4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of C1QTNF4 mRNA | CTD | PMID:20938992 | Licochalcone B | increases expression | ISO | C1QTNF4 (Homo sapiens) | 6480464 | licochalcone B results in increased expression of C1QTNF4 mRNA | CTD | PMID:33647349 | lipopolysaccharide | increases expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of C1QTNF4 mRNA | CTD | PMID:15919760 | maneb | multiple interactions | ISO | C1qtnf4 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of C1QTNF4 mRNA | CTD | PMID:36117858 | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of C1QTNF4 mRNA | CTD | PMID:28801915 | methapyrilene | increases methylation | ISO | C1QTNF4 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of C1QTNF4 promoter | CTD | PMID:30157460 | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of C1QTNF4 mRNA | CTD | PMID:30047161 | panobinostat | multiple interactions | ISO | C1QTNF4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of C1QTNF4 mRNA | CTD | PMID:27188386 | panobinostat | decreases expression | ISO | C1QTNF4 (Homo sapiens) | 6480464 | panobinostat results in decreased expression of C1QTNF4 mRNA | CTD | PMID:26272509 | paraquat | multiple interactions | ISO | C1qtnf4 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of C1QTNF4 mRNA | CTD | PMID:36117858 | PCB138 | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 | PCB138 | multiple interactions | ISO | C1qtnf4 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | phenobarbital | affects expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | Phenobarbital affects the expression of C1QTNF4 mRNA | CTD | PMID:19136022 | phenylmercury acetate | decreases expression | ISO | C1QTNF4 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of C1QTNF4 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | C1QTNF4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of C1QTNF4 mRNA | CTD | PMID:27188386 | pirinixic acid | affects expression | ISO | C1qtnf4 (Mus musculus) | 6480464 | pirinixic acid affects the expression of C1QTNF4 mRNA | CTD | PMID:19136022 | resveratrol | multiple interactions | ISO | C1QTNF4 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of C1QTNF4 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | ISO | C1QTNF4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | decreases expression | ISO | C1QTNF4 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of C1QTNF4 mRNA | CTD | PMID:29301061 | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of C1QTNF4 mRNA | CTD | PMID:30047161 | thimerosal | decreases expression | ISO | C1QTNF4 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of C1QTNF4 mRNA | CTD | PMID:27188386 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of C1QTNF4 mRNA | CTD | PMID:34492290 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of C1QTNF4 mRNA | CTD | PMID:33387578 | trichostatin A | decreases expression | ISO | C1QTNF4 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of C1QTNF4 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | C1QTNF4 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of C1QTNF4 mRNA | CTD | PMID:27188386 | valproic acid | increases methylation | ISO | C1QTNF4 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of C1QTNF4 gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | C1QTNF4 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of C1QTNF4 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | C1QTNF4 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of C1QTNF4 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | C1QTNF4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of C1QTNF4 mRNA | CTD | PMID:27188386 | |